Hemophilia Patient Receives FDA Approved Gene Therapy Treatment Likely To Eliminate The Need For Preventative Factor Replacement
July 31, 2024 04:00 ET
|
Cure 4 The Kids Foundation
LAS VEGAS, July 31, 2024 (GLOBE NEWSWIRE) -- Cure 4 The Kids Foundation (C4K) announced it has completed Nevada’s first successful infusion of Hemgenix®, a gene therapy option for adult patients...
2023 Annual Eric Dostie Memorial College Scholarship Recipients
November 13, 2023 16:34 ET
|
FFF Enterprises.com
TEMECULA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises Inc. announces its 2023 scholarship recipients. The scholarship program...
Bleeding Disorders Market to Reach $26 Billion, Globally, by 2032 at 6.6% CAGR: Allied Market Research
June 22, 2023 08:40 ET
|
Allied Market Research
Portland, OR, June 22, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Bleeding disorders Market by Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease and...
Bleeding Disorders Treatment Market will reach to USD 31.44 billion by 2029, at a CAGR of 8.9%% by 2029 : GreyViews
December 07, 2022 09:00 ET
|
GreyViews
Pune India, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
2020 Annual Eric Dostie Memorial College Scholarship Winners
September 28, 2020 09:00 ET
|
FFF Enterprises.com
Temecula, Sept. 28, 2020 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc., announces its 2020 scholarship recipients. The scholarship program...